MYC and diffuse large B-cell lymphoma: The high expression proportion of MYC in EBV+DLBCL and EBV-negative DLBCL patients was statistically significant (P < 0.05), while the expression of KMT2D was not statistically significant (P > 0.05) (Figures 3C,D, Table 2).